medigraphic.com

2004, Número s2

<< Anterior Siguiente >>

Arch Cardiol Mex 2004; 74 (s2)


¿Cuándo cardiovertir y cuándo sólo modular la respuesta ventricular? Lineamientos de vanguardia

Cordero CJA

Idioma: Español
Referencias bibliográficas: 10
Paginas: 298-301
Archivo PDF: 46.16 Kb.


RESUMEN

La fibrilación auricular es la causa de la tercera parte de los ingresos hospitalarios en las clínicas de arritmias cardíacas. El éxito en su tratamiento depende de medidas como: el control del ritmo ventricular, la anticoagulación, el uso de bloqueadores adrenérgicos tipo beta y la cardioversión eléctrica o farmacológica.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Benjamín EJ, Levy D, Vaziri SM, D´Angostino RB, Belanger AJ, Wolf PA: Independent risk factors for atrial fibrillation in a population-based cohort: The Framingham Heart Study. J Am Med Assoc 1994; 271: 840-4.

  2. Chugh SS, Blackshear JL, Shen WK, Hammill SC, Gersh BJ, DPhill ChB: Epidemiology and Natural History of Atrial Fibrillation: Clinical Implications. J Am Coll Cardiol 2001; 37: 371-378.

  3. Kowey PR, Gan-Xin Y, Winkel E, Kao W: Pharmacologic and nonpharmacologic options to Mantein Sinus Rhythm: Guideline-Based and New Approaches. Am J Cardiol 2003; 91(Suppl.): 33D-38D.

  4. Petersen P, Gring M, Alder J: Ximelagatran Versus Warfarin for Strok Prevention in Patients With Nonvalvular Atrial Fibrillation. SPORTIF II. A Dose-Guiding, Tolerability, and Safety. J Am Coll Cardiol 2003; 41: 1445-1451.

  5. Hohnloser SH, Kuck K-H, Lilienthal J. For the PIAF Investigators: Rhythm or rate control in atrial fibrillation-Pharmacologic Intervention in Atrial Fibrillation (PIAF): A Randomized trial. Lancet 2000; 356: 1789-1794.

  6. Brignole M, Menozzi C, Gasparini M, Bongiorni MG, Botto GL, Ometto R, Alboni P, et al. For the PAF 2 Investigators: An evaluation of the strategy of maintenance of sinus rhythm by antiarrhythmic drug therapy after ablation and pacing therapy in patients with paroxysmal atrial fibrillation. Eur Heart J 2002; 23: 892-900.

  7. The AFFIRM Investigators: A Comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med 2002; 347: 1825-1833.

  8. Van Gelder IC, Hagens VE, Bosker HA, Kingma JH, Kamp O, Kingma T, Said SA, Darmanata JI, Timmermans AJ, Tijssen JG, Crijns HJ. For the RACE Investigators: A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation. N Engl J Med 2002; 347: 1834-1840.

  9. Carlsson J, Miketic S, Windeler J, Cuneo A, Haun S, Micus S, Walter S, Tebbe U, for the STAF Investigators: Randomized trial of rate-control versus rhythm-control in persistent atrial fibrillation: STAF Trial. J Am Coll Cardiol 2003; 41: 1690-1696.

  10. Klein AL, Grima RA, Murria RS, et al: Use os transesophageal echocardiography to guide cardioversion in patients with atrial fibrillation. N Engl J Med 2001; 344: 1411-1420.




2020     |     www.medigraphic.com